跳至主要内容
临床试验/NCT07360158
NCT07360158招募中不适用

Post-market Study for the CorSky Family of ICDs

Biotronik SE & Co. KG7 个研究点 分布在 4 个国家目标入组 151 人开始时间: 2026年6月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
151
试验地点
7
主要终点
CorSky-related SADE-d free rate at 6 months

研究概览

简要总结

The CorSky family is BIOTRONIK´s new generation of ICDs. They are the successor devices of the current Acticor/Rivacor family and inherit all iShock/iShock_BC (Ilivia Neo, Intica Neo) implant and programmer software features.

The new features of CorSky Family are either true novel BIOTRONIK ICD features or mainly driven by unification with the Amvia pacemaker family (Amvia Edge, -Sky).

The goal of the study is to confirm the safety and performance of the CorSky Family of ICDs and CRT-Ds.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Standard indication for ICD or CRT-D therapy according to clinical guidelines
  • Planned for de novo implantation of an ICD/CRT-D, or upgrade/exchange from existing ICD/CRT-D or pacemaker
  • Ability to understand the nature of the study.
  • Ability and willingness to perform all on-site follow-up visits at the study site.
  • Ability and willingness to use the CardioMessenger and acceptance of the BIOTRONIK Home Monitoring® concept.

排除标准

  • For VR-T DX and CRT-DX: Permanent atrial tachyarrhythmia
  • For VR-T DX and CRT-DX: Patients requiring atrial pacing
  • Planned for His-Bundle-Pacing
  • Planned cardiac surgical procedures or interventional measures other than the study procedure within the next 12 months
  • Pregnant or breast feeding.
  • Age less than 18 years.
  • Participation in an interventional clinical investigation in parallel to this study. ,
  • Life-expectancy less than 12 months.

结局指标

主要结局

CorSky-related SADE-d free rate at 6 months

时间窗: 6 months

CorSky-related SADE-d free rate at 6 months

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验

BIO|MASTER.CorSky Family Post-market Study for the... | 临床试验